西安思迈尔电子科技有限公司是集研发、生产、销售、服务为一体的安防检测电子产品制造商。
暂无描述...
专利申请交给，20年专利申请经验，国家知识产权局指定专利服务代理机构，对接全球170个专利数据库。专业提供发明专利申请、外观专利申请、实用新型专利申请、涉外专利申请服务。专利代理费用低，公司资质与实力双保障，专利申请再无后顾之忧。
贵州坤卓科技是从一家初始资本只有100万元人民币的民营小企业，稳健发展为集有色矿产资源、商务咨询、地产建设、装饰装潢、电子技术、生物医药等为主体的民营企业集团。
广东绿保纸塑纸托厂是专业定制纸浆模塑、环保纸托、纸托包装、纸托面具、纸蛋托、纸托盘等可降解可回收的环保纸托包装。白浆黄浆灰浆纸托均可按图纸设计定制，纸托厂拥有先进纸托模具，异型纸托开模打样仅需15天。
览众数据
天源新能源-太阳使者，水的搬运工，全球光伏水利系统应用解决方案供应商，光伏扬水系统、光伏提水系统、太阳能光伏水泵、光伏海水淡化系统、光伏扬水逆变器专业制造商。
沃克能源（业界公认的水燃料氢氧机发源地）18年专业研发生产供应:氢氧机,氢氧焊机,水焊机,氢氧焰漆包线焊接机,变压器铜排焊接机,安瓿瓶熔封机,玻璃管真空封口机,咨询热线:0731-83998496
WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.